Renal Cancer — Clinical Studies in the U.S.A.
The five year survival for untreated renal cell cancer is approximately 2%. This increases to 30 – 47% following simple nephrectomy whereas the overall five year survival following radical (perifascial) nephrectomy is 57 – 80%. Ten year survivals for renal cell cancer overall are 17 – 27% for simple nephrectomy and 40 – 66% following radical nephrectomy (1–5).
KeywordsRenal Cell Carcinoma Renal Cell Renal Cell Cancer Radical Nephrectomy Medroxyprogesterone Acetate
Unable to display preview. Download preview PDF.
- 1.C.J. Robson, Radical nephrectomy for renal cell carcinoma, J. Urol. 89: 37 (1968).Google Scholar
- 6.M.H. Harmer, “TNM Classification of Malignant Tumors”, 3rd ed., International Union Against Cancer, Geneva (1978).Google Scholar
- 8.E.M. Hersh, S. Wallace, D.E. Johnson, and R.B. Bracken, Immunologic studies in human cancer, in: Cancer of the Genitourinary Tract,” D.E. Johnson and M.L. Samuels, eds., Raven Press, New York (1979), p. 47.Google Scholar
- 9.S. Wallace, V. Chuang, B. Green, D.A. Swanson, R.B. Bracken, and D.E. Johnson, Diagnostic radiology in renal carcinoma, in: Cancer of the Genitourinary Tract,” D.E. Johnson and M.L. Samuels, eds., Raven Press, New York (1979), p. 33.Google Scholar
- 10.D.A. Swanson, The current immunologic studies of renal carcinoma, Cancer Bull. 31: 36 (1979).Google Scholar
- 13.R.M. Bukowski, C. Jroppe, R. Reimer, J. Weich, and J.S. Hewlett, Immunotherapy (IT) of metastatic renal cell carcinoma, Proc. Amer. Soc. Clin. Oncol. 20: 402 (1979).Google Scholar